GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value ($000): $586,066 (100.0% shares, 0.0% debt)

Holdings (39)

ZOGENIX INC CMN 7.7%
Value ($000) $44,909 Shares 1,121,331 Est. Cost $14.10 Unrealized
ARENA PHARMACEUTICALS, INC. CMN 6.8%
Value ($000) $39,987 Shares 1,177,119 Est. Cost $16.87 Unrealized
KURA KURA ONCOLOGY, INC. CMN 5.7%
Value ($000) $33,618 Shares 2,197,283 Est. Cost $10.47 Unrealized +40.7%
SAGE THERAPEUTICS, INC CMN 5.6%
Value ($000) $32,942 Shares 200,000 Est. Cost $94.62 Unrealized
GLOBAL BLOOD THERAPEUTICS, INC. CMN 5.4%
Value ($000) $31,606 Shares 803,205 Est. Cost $28.28 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC CMN 5.3%
Value ($000) $31,036 Shares 400,000 Est. Cost $43.70 Unrealized +56.1%
RIGEL PHARMACEUTICALS INC CMN 5.2%
Value ($000) $30,608 Shares 7,888,581 Est. Cost $3.31 Unrealized
FOAMIX PHARMACEUTICALS LIMITED CMN 4.9%
Value ($000) $28,738 Shares 4,781,708 Est. Cost $7.50 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC CMN 4.0%
Value ($000) $23,332 Shares 4,751,883 Est. Cost $4.94 Unrealized -1.9%
AIMMUNE THERAPEUTICS, INC. CMN 3.7%
Value ($000) $21,692 Shares 573,550 Est. Cost $23.50 Unrealized
SPARK THERAPEUTICS INC CMN 3.6%
Value ($000) $21,128 Shares 410,900 Est. Cost $51.42 Unrealized
PTCT PTC THERAPEUTICS, INC. CMN 3.1%
Value ($000) $18,111 Shares 1,085,800 Est. Cost $12.42 Unrealized +36.3%
NVCR NOVOCURE, LTD. CMN 3.0%
Value ($000) $17,762 Shares 879,286 Est. Cost $19.34 Unrealized -0.4%
CONCERT PHARMACEUTICALS INC CMN 3.0%
Value ($000) $17,319 Shares 669,472 Est. Cost $17.06 Unrealized
NEWLINK GENETICS CORPORATION CMN 2.7%
Value ($000) $16,115 Shares 1,987,099 Est. Cost $8.11 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS, INC. CMN 2.7%
Value ($000) $16,000 Shares 2,000,000 Est. Cost $6.33 Unrealized +26.8%
AXOVANT SCIENCES LTD CMN 2.6%
Value ($000) $15,020 Shares 2,850,000 Est. Cost $5.28 Unrealized
CPRX CATALYST PHARMACEUTICAL INC.CMN 2.5%
Value ($000) $14,926 Shares 3,817,288 Est. Cost $3.30 Unrealized 0.0%
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. CMN 2.3%
Value ($000) $13,495 Shares 500,192 Est. Cost $26.98 Unrealized
SVRA SAVARA INC CMN 2.2%
Value ($000) $12,903 Shares 869,500 Est. Cost $11.47 Unrealized 0.0%
VNDA VANDA PHARMACEUTICALS INC. CMN 2.1%
Value ($000) $12,122 Shares 797,531 Est. Cost $12.36 Unrealized +20.0%
WVE WAVE LIFE SCIENCES PTE LTD CMN 2.0%
Value ($000) $11,621 Shares 331,085 Est. Cost $29.15 Unrealized 0.0%
REVANCE THERAPEUTICS INC CMN 1.8%
Value ($000) $10,725 Shares 300,000 Est. Cost $35.75 Unrealized
GW PHARMACEUTICALS PLC ADR CMN 1.7%
Value ($000) $9,901 Shares 75,000 Est. Cost $132.01 Unrealized
GLOBAL BLOOD THERAPEUTICS, INC. CMN 1.3%
Value ($000) $7,870 Shares 200,000 Est. Cost $28.28 Unrealized
DBV TECHNOLOGIES SA SPONSORED ADR CMN 1.3%
Value ($000) $7,703 Shares 313,140 Est. Cost $35.48 Unrealized
ACCELERON PHARMA INC CMN 1.3%
Value ($000) $7,347 Shares 173,124 Est. Cost $28.27 Unrealized
INCY INCYTE CORPORATION CMN 1.1%
Value ($000) $6,660 Shares 70,323 Est. Cost $104.52 Unrealized 0.0%
CIDARA THERAPEUTICS, INC. 0.9%
Value ($000) $5,440 Shares 800,000 Est. Cost $6.80 Unrealized
ACORDA THERAPEUTICS INC CMN 0.7%
Value ($000) $4,290 Shares 200,000 Est. Cost Unrealized
CORBUS PHARMACEUTICALS HOLDINGS, INC. CMN 0.7%
Value ($000) $4,260 Shares 600,000 Est. Cost $7.10 Unrealized
AMARIN CORPORATION PLC SPONSORED ADR CMN 0.7%
Value ($000) $4,238 Shares 1,056,825 Est. Cost $4.03 Unrealized
JOUNCE THERAPEUTICS INC CMN 0.6%
Value ($000) $3,732 Shares 292,673 Est. Cost $12.75 Unrealized
KADMON HOLDINGS INC CMN 0.5%
Value ($000) $3,042 Shares 840,303 Est. Cost $3.62 Unrealized
MYOVANT SCIENCES LTD CMN 0.3%
Value ($000) $2,029 Shares 160,530 Est. Cost $12.34 Unrealized
SELECTA BIOSCIENCES, INC. 0.3%
Value ($000) $1,745 Shares 177,900 Est. Cost $19.86 Unrealized
DERMIRA INC CMN 0.2%
Value ($000) $1,214 Shares 43,637 Est. Cost $27.82 Unrealized
CONNECTURE INC 0.1%
Value ($000) $660 Shares 4,127,232 Est. Cost $9.01 Unrealized
STREAMLINE HEALTH SOLUTNS, INC CMN 0.0%
Value ($000) $220 Shares 130,137 Est. Cost $6.45 Unrealized